We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE
Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada
Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in CanadaView Video
Roundtable Discussion; The Future of Mineral Sands
Roundtable Discussion; The Future of Mineral SandsView Video

Latest Share Chat

TOP NEWS: Favourable Forex Helps Croda Revenue But Profit Falls

Wed, 24th Jul 2019 09:42

(Alliance News) - Specialty chemicals firm Croda International PLC on Wednesday reported a drop in profit, though a weaker sterling has helped sales.

Pretax profit for the six months to June fell 2.7% to GBP166.2 million, with sales rising 1.7% to GBP714.7 million, amid a "favourable benefit" from the pound's weakness.

On an adjusted basis, core business sales rose 2.4% at reported rates, but fell 0.4% at constant currency, to GBP657.9 million, while adjusted pretax profit was down 2.5% at reported currency and 3.5% constant to GBP170.6 million.

Croda, a FTSE 100 member, has increased its interim dividend by 3.9% to 39.5 pence per share.

"We have delivered a resilient performance in challenging market conditions and against strong prior year comparatives, a testament to Croda's focused strategy. Although Personal Care was significantly impacted by the US-China trade dispute and new sales legislation in China, we saw growth across the rest of the sector," said Chief Executive Steve Foots.

"An excellent performance in Life Sciences ensured overall progress in consumer markets, whilst Performance Technologies slowed in line with the wider industry, due to softer end markets in automotive and polymers."

Looking segmentally, Life Sciences grew revenue by 16% at reported rates and adjusted operating profit by 19%, reaching GBP184.3 million and GBP56.4 million respectively.

Performance Technologies' revenue fell 3.9%, however, to GBP226.8 million, with adjusted operating profit down 11% to GBP40.8 million. Personal Care revenue declined by 0.4% to GBP246.8 million, and adjusted operating profit by 2.7% to GBP82.1 million.

Looking ahead, Croda has a "strong" pipeline, with Life Sciences expected to continue to progress. Personal Care will remain subdued in the US, but Asia should pick up, while Performance Technologies is likely to tread water "until end markets improve".

"Based on the current challenging economic conditions remaining unchanged, overall we expect a slight improvement in performance in the second half of the year versus the prior year comparator," said Croda.

Shares were 3.4% lower on Wednesday morning at a price of 4,654.00 pence each.

Related Shares

More News
24 Apr 2024 15:09

London close: Stocks finish weaker after earlier gains

(Sharecast News) - London markets closed the day weaker on Wednesday, reversing earlier gains as Wall Street stocks opened lower, although mining stoc...

24 Apr 2024 11:55

LONDON MARKET MIDDAY: Investors shake off pre-US inflation nerves

(Alliance News) - The FTSE 100 in London was higher at midday on Wednesday, as investors look ahead to the US Federal Reserve's next test on Friday.

24 Apr 2024 07:50

Croda backs FY profit guidance even as Q1 sales decline

(Sharecast News) - Croda backed its full-year profit guidance on Wednesday despite a decline in first-quarter sales, as it hailed an "encouraging" sta...

24 Apr 2024 07:42

LONDON BRIEFING: Lloyds profit takes hit; Jet2 cuts guidance

(Alliance News) - Stocks in London are set to open higher on Wednesday, as the release of some key US data edges closer

17 Apr 2024 13:59

UK shareholder meetings calendar - next 7 days

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.